Lonza Group Ltd is a contract research, development and manufacturing (CRDMO) company that provides services to the pharmaceutical and biotechnology industries. The company operates through three main business platforms: Integrated Biologics, which includes Mammalian and Drug Product Technology Platforms; Advanced Synthesis, comprising Bioconjugates and Small Molecules Technology Platforms; and Specialized Modalities, which covers Cell & Gene, Microbial, Bioscience, and mRNA Technology Platforms. Lonza serves customers globally, supporting the development and production of biologics, small molecules, and advanced therapies. The company acquired the Vacaville site to expand its manufacturing capacity. In 2021, Lonza divested its Specialty Ingredients business, which was subsequently renamed Arxada.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Drug Manufacturers - Specialty & Generic Homepage lonza.com
Sector Healthcare IR page lonza.com
Tags
contract manufacturing, biologics, small molecules, cell and gene therapy, mrna, bioscience, microbial fermentation, drug product development, Integrated Biologics, Advanced Synthesis, Specialized Modalities, Mammalian Technology Platform, Drug Product Technology Platform, Bioconjugates Technology Platform, Small Molecules Technology Platform, Cell & Gene Technology Platform, Microbial Technology Platform, Bioscience Technology Platform, mRNA Technology Platform, Arxada
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E 8.25
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE —
ROI —
ROIC —
Profit margin 9.7%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) -40.0%
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 6.574B 6.717B 6.223B 5.409B 4.508B
Net profit 636M 654M 1.215B 2.944B 869M

Figure FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 79.97 79.97 79.97 79.97 —
P/E 5y avg 8.41 8.47 — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Lonza Group Ltd (ticker O6Z), listed in Singapore.

ETFs Holding Lonza Group Ltd

ETF Weight in ETF Shares Market value As of
PCIG 4.91% 2,032 $ 1.372M Jun 30, 2026
BKCI 3.26% 6,154 $ 4.28M Jul 31, 2026
TXUG 3.02% 187 $ 133.454K Aug 31, 2026
GDOC 2.81% 771 $ 550.23K Aug 31, 2026
MTRA 2.78% 5,574 $ 3.882M Jul 31, 2026
IGGY 1.47% 92 $ 65.657K Aug 31, 2026
SROI 0.65% 175 $ 121.696K Jul 31, 2026
FWD 0.61% 27,159 $ 19.382M Aug 31, 2026
DFIV 0.58% 162,679 $ 129.792M Nov 12, 2026
UMMA 0.45% 1,855 $ 1.324M Aug 31, 2026
RINT 0.40% 824 $ 556.608K Jun 30, 2026
AVSD 0.30% 1,392 $ 1.105M Nov 16, 2026
AVDE 0.28% 67,557 $ 53.636M Nov 16, 2026
DFAI 0.24% 53,833 $ 42.95M Nov 12, 2026
TIER 0.22% 110 $ 76.668K Jul 31, 2026
NTSI 0.21% 1,539 $ 1.041M Jun 30, 2026
DFIC 0.16% 31,468 $ 25.107M Nov 12, 2026
DXIV 0.14% 422 $ 336.69K Nov 12, 2026
VNIE 0.10% 14 $ 9,472.76 Jun 30, 2026
DFAX 0.08% 12,695 $ 10.129M Nov 12, 2026
FENI 0.03% 5,194 $ 3.509M Jun 30, 2026